Serious Adverse Events associated with investigator-led trials can be reported to the HPRA using our online report form.
Further information on safety reporting is available from the detailed guidance on the collection, verification and presentation of adverse event/reaction reports arising from clinical trials on medicinal products for human use (European Commission website). In addition, this guidance sets out the responsibilities of the concerned parties.
By using this website, you consent to the use of cookies in accordance with the HPRA Cookie Policy. For more information on cookies, see our cookie policy.